CONTRASTING FEATURES AND RESPONSES TO TREATMENT OF SEVERE CHRONIC ACTIVE LIVER-DISEASE WITH AND WITHOUT HEPATITIS-BS ANTIGEN

被引：168

作者：

SCHALM, SW

SUMMERSKILL, WHJ

GITNICK, GL

ELVEBACK, LR

机构：

[1] MAYO CLIN & MAYO FDN, GASTROENTEROL UNIT, ROCHESTER, MN 55901 USA

[2] MAYO CLIN & MAYO FDN, MED RES STATISTICS SECT, ROCHESTER, MN 55901 USA

[3] UNIV CALIF LOS ANGELES, DEPT GASTROENTEROL, LOS ANGELES, CA 90024 USA

来源：

GUT | 1976年 / 17卷 / 10期

关键词：

D O I：

10.1136/gut.17.10.781

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：781 / 786

页数：6

共 26 条

[1]

ARONOFF A, 1973, CAN MED ASSOC J, V108, P43

[2] CHRONIC ACTIVE LIVER-DISEASE - RANGE OF HISTOLOGIC LESIONS, THEIR RESPONSE TO TREATMENT, AND EVOLUTION [J].

BAGGENSTOSS, AH ;

SCHOENFIELD, LJ ;

SUMMERSKILL, WH ;

SOLOWAY, RD ;

ELVEBACK, LR .

HUMAN PATHOLOGY, 1972, 3 (02) :183-+

[3] A SERUM ANTIGEN (AUSTRALIA ANTIGEN) IN DOWNS SYNDROME LEUKEMIA AND HEPATITIS [J].

BLUMBERG, BS ;

GERSTLEY, BJ ;

HUNGERFO.DA ;

LONDON, WT ;

SUTNICK, AI .

ANNALS OF INTERNAL MEDICINE, 1967, 66 (05) :924-+

[4]

BULKLEY BH, 1970, LANCET, V2, P1323

[5] THE COMPARISON OF PERCENTAGES IN MATCHED SAMPLES [J].

COCHRAN, WG .

BIOMETRIKA, 1950, 37 (3-4) :256-266

[6]

COMBES B, 1971, LANCET, V2, P234

[7] CONTROLLED PROSPECTIVE TRIAL OF CORTICOSTEROID THERAPY IN ACTIVE CHRONIC HEPATITIS [J].

COOK, GC ;

MULLIGAN, R ;

SHERLOCK, S .

QUARTERLY JOURNAL OF MEDICINE, 1971, 40 (158) :159-+

[8]

DEGROOTE J, 1968, LANCET, V2, P626

[9]

DUDLEY FJ, 1972, LANCET, V1, P1388

[10] SERUM AUTOANTIBODIES AND IMMUNOGLOBULINS IN HEPATITIS-ASSOCIATED ANTIGEN (HAA)-POSITIVE AND (HAA)-NEGATIVE LIVER-DISEASE [J].

DUDLEY, FJ ;

OSHEA, MJ ;

AJDUKIEWICZ, A ;

SHERLOCK, S .

GUT, 1973, 14 (05) :360-364

← 1 2 3 →